|Year : 2020 | Volume
| Issue : 1 | Page : 13-16
A rare histomorphological coexistence of clear cell carcinoma and mucinous cystadenoma of the ovary in a young female with brief review of literature
Syeda Firdos Jamil, Neha Sethi, Anjali Sharma, Kirti Pandya
Bhagwan Mahveer Cancer Hospital and Research Institute, Jaipur, Rajasthan, India
|Date of Submission||18-Feb-2020|
|Date of Acceptance||03-Jun-2020|
|Date of Web Publication||28-Jul-2020|
Syeda Firdos Jamil
Plot No. 17, Mukundgarh House, Sansar Chandra Road, Behind City Centre, Near Red Tomato Palace, Jaipur - 302 001, Rajasthan
Source of Support: None, Conflict of Interest: None
Concomitant clear cell carcinoma of the ovary and mucinous cystadenoma of the ovary in the absence of endometriosis are rare entities with very few cases cited in the literature. They pose diagnostic challenge as the differential diagnosis spans from germ cell tumor, sex cord stromal tumor, and other surface epithelial tumors. The various types of tumors have different prognosis and varied treatment protocols. The presence of advanced stage and paraneoplastic syndrome has been associated with poor prognosis. We present a case of a 35-year-old female who presented with complaints of abdominal distension and discomfort for the past 2 months. The patient underwent right-sided oophorectomy in 2016 which was diagnosed as mucinous cystadenoma. The radiological evaluation revealed an enlarged left ovary with solid cystic areas. CA-125 was marginally raised. Oophorectomy with hysterectomy was done. Histopathology showed an unusual combination of clear cell carcinoma with mucinous cystadenoma. There was no endometriosis although omental metastasis was noted. The finding was confirmed on immunohistochemistry. The occurrence of clear cell carcinoma with mucinous cystadenoma in the absence of endometriosis is extremely uncommon with very few literature studies available.
Keywords: Clear cell carcinoma, endometriosis, hepatocyte nuclear factor-1 beta, immunohistochemistry, mucinous cystadenoma, napsin A
|How to cite this article:|
Jamil SF, Sethi N, Sharma A, Pandya K. A rare histomorphological coexistence of clear cell carcinoma and mucinous cystadenoma of the ovary in a young female with brief review of literature. Int J Clinicopathol Correl 2020;4:13-6
|How to cite this URL:|
Jamil SF, Sethi N, Sharma A, Pandya K. A rare histomorphological coexistence of clear cell carcinoma and mucinous cystadenoma of the ovary in a young female with brief review of literature. Int J Clinicopathol Correl [serial online] 2020 [cited 2020 Sep 23];4:13-6. Available from: http://www.ijcpc.org/text.asp?2020/4/1/13/291085
| Introduction|| |
Clear cell carcinoma was first described in 1939 by Schiller. Clear cell carcinoma is relatively a rare tumor comprising 2.4% of all ovarian epithelial neoplasms. Most clear cell tumors are malignant, but benign and borderline clear cell tumors also occur. They are usually occur at 55 years of age. They are known to be the most common ovarian epithelial tumor associated with paraneoplastic hypercalcemia. They have unfavorable histological type and poor prognosis. Stated below is a present case of a young female having rare coexistence of clear cell carcinoma of the ovary with mucinous cystadenoma with brief review of literature.
| Case Report|| |
A 35-year-old female presented with abdominal pain and distension. Her history revealed right-sided oophorectomy which was done 2 years back, diagnosed as mucinous cystadenoma. The present contrast-enhanced computed tomographic (CECT) findings showed a left ovarian mass measuring 5 cm × 3.5 cm × 2.5 cm with solid cystic areas and suspicious mitotic activity. CEA and CA-125 were marginally raised (69 μg/ml). It was decided to perform hysterectomy with unilateral salpingo-oophorectomy and omentectomy.
On gross examination, left ovary showed intact capsule with nodular outer surface. The cut surface was solid cystic. The solid area was gray-white and necrotic. The cyst was smooth walled and filled with mucinous fluid. On histopathological examination, tumor cells were found to be arranged in the tubulocystic and papillary pattern. Cells have abundant clear-to-fine granular cytoplasm with irregular chromatin and inconspicuous nucleoli. A focus of mucinous cystadenoma was seen away from the tumor with normal ovarian stroma in between, but no evidence of endometriosis was identified [Figure 1]. Necrosis along with lymphovascular and perineural invasion was seen. Mucicarmine and PAS stain showed intraluminal and apical membrane staining, but no intracytoplasmic staining was seen. Immunohistochemical profile showed expression of CK, CK7, napsin A, and EMA in the tumor cells and immunonegative for glypican, SALL4, RCC, P53, WT1, and ER [Figure 2] and [Figure 3]. On the basis of morphology and immunohistochemistry, diagnosis of clear cell carcinoma was made. Omentum also showed metastatic carcinoma. Tumor cells were also present in the outer wall of the myometrium, cervix, and left fallopian tube. Hence, the patient was diagnosed with T3 staging.
|Figure 1: Clear cell carcinoma with mucinous cystadenoma - (a) Ovarian tissue showing clear cell carcinoma with mucinous cystadenoma (H and E, ×10). (b) Area exhibiting lining epithelium of mucinous cystadenoma (×40). (c) Clear cell carcinoma consisting of polygonal cells with clear cytoplasm (×40). (d) Clear cell carcinoma shows tubulocystic patterns (H and E, ×40)|
Click here to view
|Figure 2: Immunohistochemical study for (a-d) mucinous cystadenoma and (e-g) clear cell carcinoma. Mucinous cystadenoma cells are positive for CK (a), CK7 (b), and EMA (c) and immunonegative for WT1 (d). Clear cell carcinoma cells are immunopositive for CK (e), CK7 (f), and EMA (g) and immunonegative for WT1 (h)|
Click here to view
|Figure 3: Immunohistochemical study for (a) clear cell carcinoma and (b) mucinous cystadenoma. Clear cell carcinoma showing immunopositivity for napsin A (a). Mucinous cystadenoma showing immunonegativity for napsin A (b)|
Click here to view
| Discussion|| |
Clear cell carcinoma is a rare ovarian epithelial neoplasm. Initially, it was thought to be mesonephric in origin; however, due to ultrastructural similarities with Mullerian epithelium, its epithelial origin is now established.
The mean age of presentation is 55 years in clear cell carcinoma. In previously reported cases of clear cell carcinoma with mucinous lesion by Dutt and Berney, Uddin et al., Wani and Notohara, and Nakamura et al., older age group ranging between 47 and57 years has been associated with these tumors. However, the present case is unique as it was diagnosed at a very young age of 35 years. Similarly, the literature studies have documented large-sized tumors with size 10–30 cm, whereas in our study, the tumor size is 5 cm.
The most common differentials to be kept in mind are yolk sac tumor, metastatic clear cell RCC, and serous adenocarcinoma ovary. Others differentials are dysgerminoma, Krukenberg tumor, and struma ovarii. Differentiating histomorphological features and immunohistochemistry are demonstrated in [Table 1].
|Table 1: Differential diagnosis of clear cell carcinoma of ovary with differentiating histomorphological and immunohistochemistry features|
Click here to view
On immunohistochemical studies, clear cell carcinoma shows positive staining for CK, CK7, EMA, napsin A, PAX8, BerEP4, and vimentin, while ER, PR, WT1, and P53 are usually negative. Hepatocyte nuclear factor-1 beta (HNF-1B) emerged as a sensitive marker for clear cell carcinoma showed nuclear positivity in more than 80% of clear cell carcinomas., As HNF-1B was unavailable at our setup, we did not use it.
Napsin A is another sensitive and specific marker for distinguishing ovarian clear cell tumors from other ovarian tumors. It is also not observed in the normal surface epithelium of the ovary, epithelia of the fallopian tubes, squamous epithelium, endocervical epithelium, or endometrium of the uterus and hence is a useful marker.
Associations between clear cell carcinoma and mucinous lesions without endometriosis are very rare. In a rare case published by Dutt and Berney  in 2000, they showed a large clear cell carcinoma of the ovary blending imperceptibly with cyst lined by benign mucinous epithelium without evidence of endometriosis. It suggested the origin of clear cell carcinoma in the background of mucinous cystadenoma. However, it was criticized by McCluggage, as they suggested that the mucinous areas represented mucinous metaplasia of the endometriotic cyst of the ovary and not a true mucinous cystadenoma. Later on, Uddin et al. in 2007 reported a case where there were separate foci of mucinous cystadenoma and endometriosis coexisting with areas of clear cell carcinoma. There was no continuity between the areas of endometriosis and mucinous cystadenoma. This finding was supported the study by Dutt and Berney that clear cell carcinoma may arise from mucinous cystadenoma. In 2009, Wani and Notohara  also showed, in their case report, the presence of ovarian clear cell carcinoma arising in a mucinous cystadenoma in the absence of demonstrable endometriosis. Apart from this, Allende et al. in 2010 also published a case of mural nodules of clear cell carcinoma in an intestinal-type mucinous borderline tumor of the ovary without endometriosis. The studies cited above give ample literature support to belief that clear cell carcinoma arises in the background of mucinous lesion.
Among the various genetic mutations associated with clear cell carcinoma ovary, the most common is ARID1A mutation (46%–57%). PIK3CA-activating mutation and PTEN mutation are also seen in these cases. High-grade serous carcinomas are differentiated from clear cell carcinoma by the presence of TP53 mutation mainly and along with BRCA-1, BRCA-2 NOTCH 3, and AKT mutations.
As compared to other epithelial malignancies of the ovary, clear cell carcinoma has unfavorable prognosis in advanced stages and poor response to platinum-based chemotherapy. The case stated above is unique rarity of clear cell carcinoma along with mucinous cyst adenoma in the ovary arising without endometriosis in a young female with small tumor size. The poor prognosis of the tumor carries extremely important for a pathologist to recognize this entity so that appropriate and early treatment is given to the patient.
| Conclusion|| |
Clear cell carcinoma is very rare to coexist with mucinous cyst adenoma. Most of the cases arise in the background of endometriosis. However, due to limitation of number of reported cases, the origin of clear cell carcinoma from mucinous cystadenoma or endometriosis is not yet proven. The above-stated case also supports this as the clear cell carcinoma and mucinous cystadenoma were coexisting in the ovarian tissue without endometriosis. Clear cell carcinoma has poor response to platinum-based chemotherapy as compared to other epithelial malignancies of the ovary. Prognosis becomes worse as disease progresses into advanced stages.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Schiller W. Mesonephroma ovarii. Am J Cancer 1939;35:1-21.
Robert JK. Blaustein's Pathology of Female Genital Tract. 5th
ed. New Delhi (India): Springer; 2002. p. 873-8.
Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008;109:370-6.
Savvari P, Peitsidis P, Alevizaki M, Dimopoulos MA, Antsaklis A, Papadimitriou CA. Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone related protein in gynecologic malignancies: A systemic review. Onkologie 2009;32:517-23.
Dutt N, Berney DM. Clear cell carcinoma of the ovary arising in a mucinous cystadenoma. J Clin Pathol 2000;53:938-39.
Uddin Z, Yaqoob N, Kayani N, Hasan SH. Clear cell carcinoma of ovary with associated mucinous cystadenoma and endometriosis. J Pak Med Assoc 2007;57:373-5.
Wani Y, Notohara K. Ovarian clear cell carcinoma arising in a mucinous cystadenoma. Int J Gynecol Pathol 2009;28:584-8.
Nakamura E, Sato Y, Moriguchi S, Yamashita A, Higo T, Asada Y. Ovarian seromucinous borderline tumor and clear cell carcinoma: An unusual combination. Case Rep Obstetrics Gynecol 2015;2015:690891. Published online 2015 May 13.
Allende DS, Drake RD, Chen L. Mural nodules of clear cell carcinoma in a mucinous borderline tumor of the ovary: A case report. Patholog Res Int 2010;2010:438534. Published online 2010 April 13.
Yamamota S, Tsuda H, Aida S, Shimazaki H, Tamai S, Matsubara O. Immunohistochemical detection of hepatocyte nuclear factor 1 beta in ovarian and endometrial clear cell adenocarcinoma and non neoplastic endometrium. Hum Pathol 2007;38:1074-80.
Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006;19:83-9.
Yamashita Y, Nagasaka T, Naiki-Ito A, Sato S, Suzuki S, Toyokuni S, et al
. Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Mod Pathol 2015;28:111-7.
Jones S, Wang TL, Shih IeM, Mao TL, Nakayama K, Roden R, et al
. Frequent mutations of chromatin remodeling gene ARID1A
in ovarian clear cell carcinoma. Science 2010;330:228-31.
[Figure 1], [Figure 2], [Figure 3]